IN2014MN00850A - - Google Patents

Info

Publication number
IN2014MN00850A
IN2014MN00850A IN850MUN2014A IN2014MN00850A IN 2014MN00850 A IN2014MN00850 A IN 2014MN00850A IN 850MUN2014 A IN850MUN2014 A IN 850MUN2014A IN 2014MN00850 A IN2014MN00850 A IN 2014MN00850A
Authority
IN
India
Prior art keywords
methyl
compound
formula
preparation
methoxy group
Prior art date
Application number
Other languages
English (en)
Inventor
Dharmaraj Ramachandra Rao
Rajendra Narayanrao Kankan
Sanjay Naik
Maruti Ghagare
Sandip Vasant Chikhalikar
Original Assignee
Cipla Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cipla Ltd filed Critical Cipla Ltd
Priority to IN850MUN2014 priority Critical patent/IN2014MN00850A/en
Publication of IN2014MN00850A publication Critical patent/IN2014MN00850A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/62—Carboxylic acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00—Preparation of carboxylic acid esters
    • C07C67/30—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/313—Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of doubly bound oxygen containing functional groups, e.g. carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/67—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of saturated acids
    • C07C69/716—Esters of keto-carboxylic acids or aldehydo-carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom
    • C12P17/12—Nitrogen as only ring hetero atom containing a six-membered hetero ring
IN850MUN2014 2011-10-19 2012-10-19 IN2014MN00850A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN850MUN2014 IN2014MN00850A (ja) 2011-10-19 2012-10-19

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2943MU2011 2011-10-19
IN850MUN2014 IN2014MN00850A (ja) 2011-10-19 2012-10-19
PCT/GB2012/000798 WO2013057468A1 (en) 2011-10-19 2012-10-19 Process for the preparation of an endothelin receptor antagonist

Publications (1)

Publication Number Publication Date
IN2014MN00850A true IN2014MN00850A (ja) 2015-04-17

Family

ID=47116083

Family Applications (1)

Application Number Title Priority Date Filing Date
IN850MUN2014 IN2014MN00850A (ja) 2011-10-19 2012-10-19

Country Status (10)

Country Link
US (1) US20140256004A1 (ja)
EP (1) EP2768811A1 (ja)
JP (1) JP2015502916A (ja)
KR (1) KR20140091700A (ja)
AU (1) AU2012324612A1 (ja)
BR (1) BR112014009437A2 (ja)
CA (1) CA2852810A1 (ja)
IN (1) IN2014MN00850A (ja)
WO (1) WO2013057468A1 (ja)
ZA (1) ZA201403245B (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103709106A (zh) * 2013-12-06 2014-04-09 石家庄博策生物科技有限公司 一种立体选择性制备安立生坦的方法
US9133488B2 (en) 2013-12-30 2015-09-15 University Of Alaska Fairbanks Synthetic methods and compounds related thereto
CN106011194A (zh) * 2016-06-14 2016-10-12 西安大唐制药集团有限公司 一种安立生坦的制备方法
CN110437063B (zh) * 2018-05-03 2022-04-29 常州恒邦药业有限公司 安立生坦关键中间体的制备方法
CN111057725B (zh) * 2019-07-01 2023-08-18 弈柯莱生物科技(上海)股份有限公司 酮还原酶在制备(s)-1,1-二(4-氟苯基)-2-丙醇的用途及制备
CN110423741B (zh) * 2019-07-16 2021-08-17 浙江工业大学 羰基还原酶-辅酶nadp+共固定化酶及其制备与应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19533023B4 (de) 1994-10-14 2007-05-16 Basf Ag Neue Carbonsäurederivate, ihre Herstellung und Verwendung
WO1999023242A1 (en) 1997-11-04 1999-05-14 Eli Lilly And Company Ketoreductase gene and protein from yeast
DE19850301A1 (de) 1998-10-30 2000-05-04 Basf Ag Verfahren zur Racematspaltung von 2-Hydroxypropionsäuren
CA2533838A1 (en) 2003-08-11 2005-02-24 Codexis, Inc. Improved ketoreductase polypeptides and related polynucleotides
EP2350024A4 (en) 2008-11-05 2012-03-21 Msn Lab Ltd IMPROVED METHOD FOR THE PRODUCTION OF ENDOTHELIN RECEPTOR ANTAGONISTS
WO2010091877A2 (en) 2009-02-13 2010-08-19 Ratiopharm Gmbh Process for producing ambrisentan
ES2462065T3 (es) 2009-07-10 2014-05-22 Cadila Healthcare Limited Proceso mejorado para la preparación de Ambrisentán e intermedios novedosos de este

Also Published As

Publication number Publication date
AU2012324612A1 (en) 2014-05-15
JP2015502916A (ja) 2015-01-29
US20140256004A1 (en) 2014-09-11
KR20140091700A (ko) 2014-07-22
ZA201403245B (en) 2015-06-24
BR112014009437A2 (pt) 2017-04-11
CA2852810A1 (en) 2013-04-25
EP2768811A1 (en) 2014-08-27
WO2013057468A1 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
PH12016501375A1 (en) Pyridin-2-amides useful as cb2 agonists
AU2012313888A8 (en) 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH
CR20140237A (es) Procedimiento de preparación de 5-fluoro-1h-pirazolopiridinas sustituidas
ECSP12011581A (es) Inhibidores de bace
UA110354C2 (uk) Противірусні сполуки
IN2014MN02496A (ja)
IN2014MN01521A (ja)
MX2013011257A (es) Proceso para la preparacion de dronedarona por n-butilacion.
EP2590649A4 (en) PROCESS FOR SYNTHESIS OF SUBSTITUTED MORPHINANES
MX2013015308A (es) Inhibidores de proteasoma y procesos para su preparacion, purificacion y uso.
IN2014MN00850A (ja)
IN2014CN00302A (ja)
MX348702B (es) Compuestos de ciclohexano sustituidos novedosos.
IN2014DN00144A (ja)
JO3063B1 (ar) مركب مبتكر وطرق لانتاجه
IN2014DN06192A (ja)
GB201107985D0 (en) Process
MX2013000294A (es) Intermedios y procedimiento de preparación de un inhibidor específico de la trombina.
MY164880A (en) Process for the preparation of isoxazolyl-methoxy-nicotinic acids
MX2013013262A (es) Derivados de ciclododecadienona como ingredientes de perfumado.
MY160625A (en) Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation
ME00929B (me) NOVI POSTUPAK ZA DOBlJANJE KRISTALNOG OBLIKA V AGOMELATIN A
IN2014DN03245A (ja)
MX337610B (es) Proceso para la preparacion de (r)-2-acetamido-n-bencil-3-metoxipr opionamida e intermediarios de la misma.
JO3200B1 (ar) طريقة ونواتج وسيطة لتحضير أجوميلاتين